Cerebral or intracranial aneurysm is a leading cause of subarachnoid hemorrhage. It was initially treated with open surgical clipping but as rapid development of technology a less invasive endovascular coiling technique of aneurysm revolutionized the treatment. Due to tortuous anatomy of parent artery and complicated morphology and location of aneurysm there is ongoing challenge in the complete obliteration of aneurysms. To aid in the advances of treating aneurysm stent assisted endovascular coiling was introduced to give more scaffold support to parent artery and decrease events of coil protrusion from aneurysms. Many types and generation of stents were developed. One of the most recently introduced stent is low profile visualized intraluminal support (LVIS) stent. Due to its low-profile nature it can be used in 0.017-inch inner diameter microcatheter and reach small and complex vessels providing high aneurysmal neck coverage which was not possible through other traditional stent. In addition, its braided design with tantalum strands and radiopaque markers make it more visible during stent placement and post procedure stent evaluation. Despite of many advantages of LVIS stent it is related to high rate of thromboembolic complications and technical complications. Aim of this review paper was to evaluate therapeutic safety, effectiveness and feasibility of LVIS stent in endovascular coil embolization of intracranial aneurysms.
by weakness in the inner muscular layer wall of cerebral artery or vein resulting in focal dilation or ballooning of the blood vessel. The dilated vessels can become thin and rupture without any threatening signs resulting in subarachnoid hemorrhage which can lead to stroke, coma or death. Most evident division of cerebral aneurysm is considering the ruptured and unruptured lesions. Cerebral aneurysms can be classified in terms of size (small (<10 mm), large (10 -25 mm) , and giant (>25 mm) in diameter) [1] , location (Anterior circulation 90% and posterior circulation 10%) [2] . Non-saccular aneurysms (fusiform, dolichoectatic, and dissecting aneurysms) are rare with less than 0.1% incidence [3] . Saccular or berry aneurysms is the most common form of cerebral aneurysm occurring in about 1% -2% of the population and related to 80% -85% of non-traumatic subarachnoid hemorrhages [4] [5] . According to findings from an analysis of 68 prevalence studies data from 83 study populations prevalence of intracranial saccular aneurysms of 3.2% is with male: female ratio of 1:2 [6] . Intracranial aneurysms are seldomly acquired lesions; however, a rare heredity form has been related with conditions like Marfan's syndrome, Autosomal dominant polycystic kidney disease, Ehlers-Danlos syndrome type IV, fibromuscular dysplasia, sickle cell anemia, Moyamoya disease and brain arteriovenous malformation. About 5% -40% of patients with autosomal dominant polycystic kidney disease have intracranial aneurysms, and 10% -30% of patients have multiple aneurysms [7] . An important risk factor of aneurysm is family history. Reversible risk factors like alcohol consumption, smoking and hypertension increase occurrence of aneurysm [8] [9].
Background
Endovascular techniques for treating aneurysms started back to the 1970s by a Russian neurosurgeon, MD Fjodor A. Serbinenko with the introduction of proximal balloon occlusion. During 1980s, there was high rate of procedural rupture and complications those treated with endovascular balloon occlusion technique [10] . Guido Guglielmi, MD, an American neuroradiologist invented the platinum detachable micro coil, which was used to treat the first human being in 1991 and their FDA approval in 1995 gave revolution to endovascular treatment of cerebral aneurysms [11] .
Endovascular coiling has been regarded as a safe and effective alternative to surgical clipping of aneurysms [12] [13] [14] . The goal of both surgical clipping and endovascular coiling is to stop blood flow into the aneurysm. On the basis of aneurysm obliteration rate and without any evidence of aneurysmal recanalization or reoccurrence, treatment effectiveness is measured. Endovascular coiling is a good option for treating aneurysms because it is minimally invasive technique, which means no need to open skull, can be done in short time which ultimately lower anesthesia time. However, the important different between endovascular coiling and surgical clipping, includes how the aneurysm was closed.
Because comparing both coiling does not physically approximate the inner blood vessel lining, blood flow to aneurysm may occur through the incomplete compac-U. KC, G. Deng Open Journal of Radiology tion of the coils. Nevertheless, due to the risk of coil herniation or migration responsible for thromboembolic complications coil embolization of complex-shaped and wide necked aneurysms remains challenging. Advanced techniques like balloon remodeling and stent-assisted coiling for endovascular treatment of complex and wide-necked aneurysms has been developed which allow compact coil packing hence preventing coil protruding into the parent artery [15] . In addition, stents may induce flow diversion effect hence reducing blood flow towards aneurysm and provides a scaffold support around aneurysm neck which helps in new endothelial tissue growth resulting vessel wall healing and preventing circulation towards aneurysms [16] . A new self-expandable stent, the Low-profile Visualized Intraluminal Support (LVIS) device is introduced for stent assisted coil embolization cerebral aneurysms.
LVIS Device Description and Endovascular Procedure [17] [18]
The LVIS stent (MicroVention Terumo, Tustin, California, USA), which offers an option between conventional coil assist stents and flow diverters, it was designed to improve the long-term efficacy of endovascular treatment while excluding impact on side branches. The LVIS is a self-expanding, hybrid closed cell, braided stent with nitinol wires and flared ends with proximal and distal radiopaque markers, and double helical tantalum strands to help in full visualization. Due to its small cell size (<0.9 mm) it can provide better parent artery protection against small sized coils around the aneurysm neck. It has high metal to surface coverage (23% on average) as compared to other available stents which helps improving flow diversion. To deliver stent to the target site a 6F -8F guiding microcatheter is introduced through a femoral sheath into the carotid artery. Radiologic examination of target artery is performed using a biplane angiographic system, rotational angiography followed by three-dimensional reconstruction is performed to assess the 
Anticoagulation and Antiplatelet Treatment [18]
All patients prior to endovascular coiling procedure are heparinized after catheter is placed to prevent blood clotting. Blood coagulation factors are routinely monitored pre and post procedure. Patient with unruptured aneurysms are pretreated with Dual antiplatelet drugs (Aspirin 100 mg and Clopidogrel 75 mg) to decrease platelet aggregation and inhibit thrombus formation for prevention of any primary and secondary thrombotic events. Loading dose of Dual antiplatelet drugs 300 mg each should be given before stenting procedure for patient with acute ruptured aneurysmal subarachnoid hemorrhage to reduced risk of clinical vasospasm and delayed cerebral ischemia [22] . Post procedure patient are continued with daily maintenance dose of Aspirin and clopidogrel for some weeks as per patient need and followed by aspirin alone for lifelong.
Clinical and Imaging Follow-Up
Patient are clinically assessed according to Modified Rankin scale (mRS) [23] for any neurological disability or dependency in daily activities on the day of procedure and in follow up in 3 -6 -12 months (Table 1) 
Review of Articles
Regarding overall safety, effectiveness, feasibility and complications of LVIS Table 1 . Modified rankin scale.
Symptoms Grade
No symptoms at all 0 No significant disability despite symptoms; able to carry out all usual duties and activities 1 Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance 2
Moderate disability; requiring some help, but able to walk without assistance 3
Moderately severe disability; unable to walk without assistance, unable to attend to needs without assistance 4
Severe disability; bedridden, incontinent, and requiring constant nursing care and attention 5
DeadOpen Journal of Radiology stent we reviewed various original articles related to LVIS Stent from 2012-2018.
PUBMED, SCOPUS, GOOGLE SCHOLAR and RESEARCH GATE search engines were used using key words low profile visualized intraluminal support (LVIS) for articles search. We mainly focused on articles in english language about study related safety and effectiveness of LVIS, articles directly comparing LVIS stent with other stent in the endovascular treatment of cerebral aneurysms.
Articles related to surgical clipping, endovascular coiling without stent assistance, animal study and non-English language were kept on exclusion criteria (Figure 1 ).
Wei Su, Yisen Zhang et al. [25]
In this single-center retrospective study they enrolled 218 patients with various 
David Fiorella, Alan Boulos et al. [26]
This study was prospective, multicenter, interventional study done in 21 
Bradley a Gross, William J Ares et al. [28]
This study was held between November 2013 and April 2018, total 64 patients were included in which 27 patients were treated with LVIS Jr and 37 patients were treated with ATLAS stent in endovascular coil embolization of cerebral aneurysms. Objective of this study was focused on clinical comparison of LVIS Jr and ATLAS on the basis of technical success and complication rate. According to their study results initial Raymond 1 occlusion rate of aneurysm of ATLAS was higher (57% vs 41% LVIS, P = 0.03), significant greater rate Raymond 1 or 2 aneurysmal occlusion in follow up angiography results (ATLAS 100% vs 81% LVIS, P = 0.04) with minimum rate of in-stent stenosis for ATLAS (ATLAS 0% vs 19% LVIS, P = 0.04). As compared to those treated with LVIS stent this study demonstrates ALTAS stent has higher aneurysmal obliteration rate and lower in-stent stenosis rate.
Huijian Ge, Xianli et al. [29]
This single center, retrospective study was done in November 2014 to December aneurysms were reported which were treated using various stenting techniques.
Raymond class 1 and 2 obliteration was found in 87% of aneurysm on immediate post procedure angiographic results. Raymond class 1 and 2 was found in 79% and Raymond class 3 obliteration was found in 3% of treated aneurysms on Open Journal of Radiology 
Summary
In 1997 Higasida first published study about stenting technique in endovascular coiling of ruptured intracranial aneurysms; since then there is rapid development in the field of stent assisted coil embolization of cerebral aneurysms [31] .
Purpose of endovascular technique is complete obliteration, stopping intracrani- According to study [26] [34] [36] LVIS stent was highly effective in the treatment of small, wide-necked aneurysm. In previous report LVIS VS Enterprise stent they compared both stent; as a result there was no significant difference in clinical outcomes and complication of both stent but LVIS stent resulted in high complete or near complete occlusion rate of aneurysms [29] . On the basis of hemodynamic effect of stent to reduce blood flow to aneurysms, using computational fluid dynamic this study has highlighted that the single LVIS device does more flow reduction than double Enterprise device but not as compared to pipeline device but double LVIS stent has better flow diverting effect than pipeline [37] .
Hence after reviewing several articles related to LVIS stent in the coil embolization of intracranial aneurysms of different type and morphology this stent proved its safety, effectiveness and feasibility with its advance features and could be better option than other available stent. However, to reduce chances procedure related complication (thromboembolic and ischemic events), technical 
